GENEVA, Oct. 28 -- GENZYME CORPORATION (450 Water StreetCambridge, Massachusetts 02141) filed a patent application (PCT/US2025/024732) for "RECONSTITUABLE DRUG FORMULATION, MEDICAMENT CONTAINER AND METHOD OF PREPARING AN INJECTABLE MEDICAMENT" on Apr 15, 2025. With publication no. WO/2025/221759, the details related to the patent application was published on Oct 23, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): AUERNHAMMER, Daniel (c/o Sanofi-Aventis Deutschland GmbH65926 Frankfurt am Main), WANNER, Yvonne (c/o Sanofi-Aventis Deutschland GmbH65926 Frankfurt am Main)

Abstract: In one aspec...